What Is LMA Anesthesia? Placement, Uses, and Risks

A laryngeal mask airway, or LMA, is a supraglottic device that sits above the vocal cords and forms a seal around the entrance to the windpipe, providing a reliable breathing channel during general anesthesia without entering the trachea itself. Developed through a series of hand-built prototypes in the 1980s, the LMA has become one of the most widely used airway devices in modern anesthesia practice, bridging the gap between a simple face mask and a full endotracheal tube. Its role has expanded well beyond routine surgery into emergency rescue, pediatric care, and even prehospital medicine.

How an LMA Sits in the Throat

The LMA consists of a tube connected to a small inflatable cuff shaped like a shallow mask. After insertion through the mouth, the cuff settles into the hypopharynx, the curved space at the base of the tongue, and inflates to create a low-pressure seal around the laryngeal inlet.¹ The device does not pass between or through the vocal cords, which is the key difference from an endotracheal tube.

Once in place, the inflated cuff is supported from several directions: the spine presses from behind, the cartilages of the larynx cradle it from the front and sides, and the hyoid bone braces it laterally. A thin layer of mucus acts as a lubricant, so friction plays almost no role in keeping the seal.² The result is a gentle, anatomically guided fit rather than a mechanical grip, which is why LMA insertion triggers less of the body’s stress response than placing a tube directly into the trachea.

First and Second Generation Devices

The original LMA concept evolved from dental mask prototypes through dozens of hand-crafted latex models before a factory-produced silicone version appeared in 1986.³ That early design is now called a “first generation” supraglottic airway. It handled breathing well for spontaneously ventilating patients but lacked any channel for draining stomach contents.

Second generation devices added features to address that limitation. Models like the LMA Supreme, the ProSeal, the i-gel, the Ambu AuraGain, and the LMA Protector all incorporate a gastric drainage port, a separate channel that allows a tube to reach the esophagus and vent any fluid that might otherwise pool above the cuff. These newer designs also tend to achieve higher seal pressures against the airway, which matters when positive-pressure ventilation is needed. In a randomized trial comparing the AuraGain to the LMA Supreme during laparoscopic surgery, the AuraGain produced somewhat higher seal pressures (about 26 versus 21 cmH₂O), both devices had insertion success rates above 94%, and neither produced any aspiration events.⁴ In obese patients, four second generation devices all achieved oropharyngeal leak pressures above 30 cmH₂O, confirming they can maintain an adequate seal even when abdominal pressure is elevated.⁵

LMA Versus Endotracheal Tube for the Patient

From a patient’s perspective, the most noticeable difference between an LMA and an endotracheal tube shows up after surgery. Because the LMA never passes through the vocal cords, it causes less mechanical irritation to the larynx. In a randomized trial of thyroid surgery patients, sore throat and hoarseness were both significantly lower with the LMA at one, 24, and 48 hours after the operation.⁶ A trial of minimally invasive esophageal surgery found sore throat at two hours in 10% of LMA patients compared with 27% of endotracheal tube patients.⁷

The tradeoffs are not entirely one-sided. One study found that while endotracheal tube patients had more sore throat and hoarseness, LMA patients reported more swallowing discomfort in the first day or so. At 12 hours, roughly 36% of LMA patients had a sore throat compared with about 61% of intubated patients, and hoarseness lingered at 36 hours in about 10% of tube patients versus just 1% of LMA patients. But the LMA group had more mild swallowing pain at 24 hours.⁸ In practice, the swallowing discomfort from an LMA is typically mild and resolves quickly, while the voice changes from intubation can persist for days.

Recovery speed also tilts in the LMA’s favor for outpatient procedures. In a comparison of ambulatory oral surgery patients, those managed with an LMA had a recovery room stay of about 54 minutes compared with roughly 67 minutes for intubated patients, even when operative times were similar.⁹

Aspiration Risk and Other Complications

The worry that keeps anesthesiologists cautious about LMA use is aspiration: stomach contents entering the lungs. Because the LMA does not create a cuffed seal inside the trachea the way an endotracheal tube does, it theoretically offers less protection if a patient regurgitates. In practice, the risk appears very low in appropriately selected patients. A meta-analysis of published literature calculated an aspiration incidence of about 2 in 10,000 LMA uses, with no deaths or permanent disability among the reported cases.¹⁰ Most patients who aspirated had one or more predisposing factors such as emergency surgery or obesity.

A larger analysis of over 65,000 procedures using positive-pressure ventilation compared aspiration between LMAs and endotracheal tubes directly. Three cases occurred with the LMA and seven with the tube. After adjusting for confounders, the odds of aspiration with the LMA were essentially the same as with the tube. The strongest predictor of aspiration was unplanned surgery, which carried roughly a 30-fold higher risk.¹¹ That finding helps explain why anesthesiologists still prefer endotracheal tubes for emergency cases and patients with full stomachs, while feeling comfortable using LMAs for elective procedures in fasted patients.

Proper positioning matters for preventing gastric insufflation, where air is pushed into the stomach rather than the lungs. In a pediatric study, no gastric air entry occurred in any of the 51 children whose LMAs were correctly positioned, while it happened in about 10% of those with a misplaced device. Correctly positioned LMAs also tolerated higher airway pressures before leaking (25 cmH₂O versus 17 for malpositioned ones).¹²

Nerve Injuries and How to Prevent Them

Cranial nerve injuries are rare but recognized complications of supraglottic devices. A systematic review of published case reports found that nerve damage typically results from pressure on nerves that run near where the cuff sits, particularly the lingual nerve and the recurrent laryngeal nerve. Contributing factors include using the wrong device size, overinflating the cuff, poor insertion technique, and prolonged surgical positioning.¹³ Most cases resolve on their own within days to weeks. The practical takeaway is straightforward: use the manufacturer’s recommended size, inflate the cuff only to the minimum volume needed for an adequate seal, and recheck positioning if the surgical team repositions the patient.¹⁴

When the LMA Saves the Day as a Rescue Device

Some of the most dramatic uses of the LMA happen when standard intubation fails. Airway management textbooks and professional guidelines now include the LMA as a key rescue tool for the “can’t intubate, can’t ventilate” scenario, where a clinician is unable to pass a tube into the trachea and also cannot maintain oxygen levels with a face mask. In a two-year quality review, 25 cases of simultaneous difficult ventilation and difficult intubation were identified. Before the LMA was placed, the median oxygen saturation had dropped to 80%, and patients had undergone a median of four failed laryngoscopy attempts. The LMA restored ventilation in 94% of cases without complications.¹⁵

The ProSeal variant has shown particular promise in acute airway obstruction situations, often succeeding after other techniques had failed, with no reported complications across a series of rescue cases.¹⁶ Beyond immediate rescue, a specialized intubating LMA can serve as a conduit for passing an endotracheal tube through the device and into the trachea under fiberoptic guidance. One study found that an endotracheal tube was placed on the first fiberoptic attempt through an intubating LMA in 78% of patients.¹⁷

LMA Use in Children

Children present unique airway challenges: their anatomy is proportionally different from adults, and their airways are more reactive. A large pediatric study found first-attempt LMA success in about 85% of children, with second-attempt success bringing the overall rate above 94%. Predictors of first-attempt difficulty included abnormal airway anatomy, body weight under 16 kg, and age below five years.¹⁸

Where the LMA really shines in pediatrics is reducing respiratory complications. A trial in infants found that respiratory adverse events occurred in about 53% of infants managed with an endotracheal tube compared with roughly 18% in the LMA group. Serious events like laryngospasm and bronchospasm were about five times more common with the endotracheal tube.¹⁹ A systematic review and meta-analysis of pediatric laparoscopic hernia repairs confirmed fewer coughing episodes with the LMA, along with shorter anesthesia time (by about seven minutes) and faster recovery (by about five minutes).²⁰

When children are breathing on their own through an LMA, adding mild pressure support ventilation can improve gas exchange. A pediatric ambulatory surgery trial showed that pressure support lowered end-tidal carbon dioxide levels and improved tidal volumes compared with pure spontaneous breathing through the same device.²¹

Expanding Into Bigger Operations

For decades, any procedure involving abdominal insufflation with carbon dioxide (the standard for laparoscopic surgery) was considered off-limits for the LMA. The reasoning was sound: pumping gas into the abdomen pushes the diaphragm upward, increases airway pressures, and raises the theoretical risk of gastric reflux. Second generation devices with higher seal pressures and gastric drainage ports have chipped away at those restrictions. A randomized trial of laparoscopic living liver donor surgery, a procedure lasting several hours in a steep head-up position, found that a second generation LMA provided ventilation and hemodynamic stability equivalent to an endotracheal tube, with comparable postoperative outcomes.²²

The LMA has also been used successfully in obese patients, a population traditionally managed with endotracheal tubes due to higher aspiration risk and the need for greater ventilatory pressures. Both the classic LMA and the ProSeal have been compared in obese patients undergoing mechanical ventilation, with similar leak fractions of around 6% for both devices.²³ These findings do not mean every obese patient is a good candidate, but they show the device performs better than many clinicians once assumed.

Prehospital and Paramedic Use

One of the LMA’s most practical advantages is how easy it is to insert compared with an endotracheal tube. This matters enormously outside the hospital, where lighting is poor, space is cramped, and the person managing the airway may not be a physician. In a study of emergency patients managed by ambulance paramedics, the LMA Supreme was successfully placed in all 50 cases, with first-attempt success in 49 of them. Oxygenation was adequate, and the paramedics unanimously described the device as easy to use.²⁴ A separate study of advanced life support paramedics found 100% first-attempt placement with a median time to first ventilation under 10 seconds.²⁵ In several of those cases the LMA was later exchanged for an endotracheal tube or another device, but it bought critical time when seconds counted.

How Quickly Practitioners Learn the Skill

The learning curve for LMA insertion is substantially shorter than for endotracheal intubation. Novice anesthesia residents using the i-gel, a popular cuffless supraglottic device, reached acceptable proficiency after a median of about 15 insertions using strict criteria (single attempt, under 60 seconds). Even in their first 10 attempts, the success rate within two tries was already 95%.²⁶ For the ProSeal, which has a more complex insertion technique, proficiency took about 20 cases on average, with success rates climbing from 76% in the first quartile of training to 93% by the fourth.²⁷

Device design affects novice performance. When inexperienced users compared the LMA Supreme to the i-gel, the Supreme had a significantly higher first-attempt success rate of 77% versus 54%, with zero total placement failures compared to six with the i-gel.²⁸ This kind of data influences which devices emergency services and training programs stock, because in a crisis you want the tool that works reliably in less experienced hands.

Ventilation Strategies Through an LMA

Patients breathing through an LMA can be allowed to breathe entirely on their own (spontaneous ventilation), given gentle assistance (pressure support ventilation), or fully machine-ventilated (controlled positive-pressure ventilation). The evidence suggests that positive-pressure ventilation through an LMA is as safe as spontaneous breathing when performed within the device’s seal limits, with similar rates of air leak and gastric insufflation compared to an endotracheal tube.²⁹ The practical ceiling is the device’s oropharyngeal leak pressure. If the ventilator needs to push harder than the seal can hold, air escapes around the cuff and ventilation becomes inadequate. For most second generation devices, that threshold sits somewhere between 25 and 33 cmH₂O depending on the model and the patient’s anatomy.

Reusable Versus Disposable Devices

Hospitals face a choice between reusable LMAs, which are autoclaved and used up to 40 times, and single-use disposable versions. A life cycle assessment found that reusable LMAs had a more favorable environmental profile overall. The biggest environmental costs for disposable devices came from polymer production, packaging, and waste disposal. For reusable devices, washing and sterilization dominated the environmental footprint.³⁰ Despite this, many institutions have shifted toward disposables, driven by concerns about prion transmission, cross-contamination between patients, and the logistical burden of tracking reprocessing cycles. The pandemic accelerated this trend, though growing attention to healthcare’s carbon footprint has prompted some facilities to reconsider.

Where the LMA Does Not Belong

For all its versatility, the LMA has clear contraindications that have remained consistent since the device’s earliest clinical studies. Patients who have not fasted appropriately and are at high risk of vomiting generally need an endotracheal tube, because the LMA cannot prevent aspiration the way a cuffed tube inside the trachea can. Other situations where the LMA is typically avoided include patients with significant gastroesophageal reflux disease, those needing very high ventilatory pressures (such as severe lung disease or morbid obesity with respiratory compromise), operations where the surgeon needs the mouth and throat (many ear, nose, and throat procedures), and patients in positions where the airway cannot be quickly accessed if the device fails.

Emergency surgery deserves special mention. The large analysis of over 65,000 procedures identified unplanned surgery as far and away the strongest predictor of aspiration, regardless of which airway device was used.³¹ In that context, the additional protection of an endotracheal tube’s tracheal cuff is worth the trade-off in throat irritation and hemodynamic disruption. The LMA’s role in emergencies is more as a bridge or rescue tool than as a definitive airway for a full surgical case.